ClariVest Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $2.17M | Hold |
|
|||||
|
2024
Q2 | $2.17M | Sell |
|
|||||
|
2024
Q1 | $1.95M | Sell |
|
|||||
|
2023
Q4 | $6.34M | Sell |
|
|||||
|
2023
Q3 | $6.48M | Sell |
|
|||||
|
2023
Q2 | $6.99M | Sell |
|
|||||
|
2023
Q1 | $7.36M | Sell |
|
|||||
|
2022
Q4 | $6.95M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $464K | Sell |
|
|||||
|
2021
Q1 | $12.3M | Sell |
|
|||||
|
2020
Q4 | $15M | Sell |
|
|||||
|
2020
Q3 | $20M | Buy |
|
|||||
|
2020
Q2 | $13.4M | Buy |
|
|||||
|
2020
Q1 | $767K | Sell |
|
|||||
|
2019
Q4 | $750K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $5.29M | Buy |
|
|||||
|
2013
Q2 | $5.57M | Buy |
|